<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="correction"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006093</article-id><article-id pub-id-type="pmc">PMC11859681</article-id><article-id pub-id-type="doi">10.3390/ph18020152</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-18-00152</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. <italic toggle="yes">Pharmaceuticals</italic> 2022, <italic toggle="yes">15</italic>, 732</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Maksymowicz</surname><given-names>Jerzy</given-names></name><xref rid="af1-pharmaceuticals-18-00152" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Palko-&#x00141;abuz</surname><given-names>Anna</given-names></name><xref rid="af1-pharmaceuticals-18-00152" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3355-2480</contrib-id><name><surname>Sobieszcza&#x00144;ska</surname><given-names>Beata</given-names></name><xref rid="af2-pharmaceuticals-18-00152" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5364-6556</contrib-id><name><surname>Chmielarz</surname><given-names>Mateusz</given-names></name><xref rid="af1-pharmaceuticals-18-00152" ref-type="aff">1</xref><xref rid="af2-pharmaceuticals-18-00152" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8578-7487</contrib-id><name><surname>Ferens-Sieczkowska</surname><given-names>Miros&#x00142;awa</given-names></name><xref rid="af3-pharmaceuticals-18-00152" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6263-9585</contrib-id><name><surname>Skonieczna</surname><given-names>Magdalena</given-names></name><xref rid="af4-pharmaceuticals-18-00152" ref-type="aff">4</xref><xref rid="af5-pharmaceuticals-18-00152" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Wikiera</surname><given-names>Agnieszka</given-names></name><xref rid="af6-pharmaceuticals-18-00152" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1659-3288</contrib-id><name><surname>Weso&#x00142;owska</surname><given-names>Olga</given-names></name><xref rid="af1-pharmaceuticals-18-00152" ref-type="aff">1</xref><xref rid="c1-pharmaceuticals-18-00152" ref-type="corresp">*</xref><xref rid="fn1-pharmaceuticals-18-00152" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3454-5044</contrib-id><name><surname>&#x0015a;roda-Pomianek</surname><given-names>Kamila</given-names></name><xref rid="af1-pharmaceuticals-18-00152" ref-type="aff">1</xref><xref rid="c1-pharmaceuticals-18-00152" ref-type="corresp">*</xref><xref rid="fn1-pharmaceuticals-18-00152" ref-type="author-notes">&#x02020;</xref></contrib></contrib-group><aff id="af1-pharmaceuticals-18-00152"><label>1</label>Department of Biophysics and Neuroscience, Wroclaw Medical University, 50-367 Wroclaw, Poland</aff><aff id="af2-pharmaceuticals-18-00152"><label>2</label>Department of Microbiology, Wroclaw Medical University, 50-367 Wroc&#x00142;aw, Poland</aff><aff id="af3-pharmaceuticals-18-00152"><label>3</label>Department of Chemistry and Immunochemistry, Wroclaw Medical University, 50-367 Wroclaw, Poland; <email>miroslawa.ferens-sieczkowska@umw.edu.pl</email></aff><aff id="af4-pharmaceuticals-18-00152"><label>4</label>Department of Systems Biology and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland; <email>magdalena.skonieczna@polsl.pl</email></aff><aff id="af5-pharmaceuticals-18-00152"><label>5</label>Biotechnology Centre, Silesian University of Technology, 44-100 Gliwice, Poland</aff><aff id="af6-pharmaceuticals-18-00152"><label>6</label>Department of Biotechnology and General Technology of Foods, Faculty of Food Technology, University of Agriculture in Krakow, 31-120 Krakow, Poland</aff><author-notes><corresp id="c1-pharmaceuticals-18-00152"><label>*</label>Correspondence: <email>olga.wesolowska@umw.edu.pl</email> (O.W.); <email>kamila.sroda-pomianek@umw.edu.pl</email> (K.&#x0015a;.-P.); Tel.: +48-71-7841415 (O.W.); +48-71-7841415 (K.&#x0015a;.-P.)</corresp><fn id="fn1-pharmaceuticals-18-00152"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>24</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>1</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>18</volume><issue>2</issue><elocation-id>152</elocation-id><history><date date-type="received"><day>16</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>27</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>01</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><related-article related-article-type="corrected-article" ext-link-type="doi" id="ra1-pharmaceuticals-18-00152" xlink:href="10.3390/ph15060732" vol="15" page="732"/></article-meta></front><body><sec><title>Error in Figure</title><p>In the original publication [<xref rid="B1-pharmaceuticals-18-00152" ref-type="bibr">1</xref>], there was a mistake in Figure 10 as published. By mistake, we doubled panels B2&#x02013;B4 and presented them as panels C2&#x02013;C4 which of course should not be identical to panel B. This error was not intentional; however, we realized that it may lead to confusion among readers. The corrected <xref rid="pharmaceuticals-18-00152-f010" ref-type="fig">Figure 10</xref> appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><ref-list><title>Reference</title><ref id="B1-pharmaceuticals-18-00152"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maksymowicz</surname><given-names>J.</given-names></name>
<name><surname>Palko-&#x00141;abuz</surname><given-names>A.</given-names></name>
<name><surname>Sobieszcza&#x00144;ska</surname><given-names>B.</given-names></name>
<name><surname>Chmielarz</surname><given-names>M.</given-names></name>
<name><surname>Ferens-Sieczkowska</surname><given-names>M.</given-names></name>
<name><surname>Skonieczna</surname><given-names>M.</given-names></name>
<name><surname>Wikiera</surname><given-names>A.</given-names></name>
<name><surname>Weso&#x00142;owska</surname><given-names>O.</given-names></name>
<name><surname>&#x0015a;roda-Pomianek</surname><given-names>K.</given-names></name>
</person-group><article-title>The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan</article-title><source>Pharmaceuticals</source><year>2022</year><volume>15</volume><elocation-id>732</elocation-id><pub-id pub-id-type="doi">10.3390/ph15060732</pub-id><pub-id pub-id-type="pmid">35745651</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceuticals-18-00152-f010"><label>Figure 10</label><caption><p>Adherence of the <italic toggle="yes">E. coli</italic> LF82 strain to HCT 116 cells (<bold>A</bold>) in the presence of pectins during a 2 h incubation period. The means of three experiments &#x000b1; SD are presented. Statistical significance (* <italic toggle="yes">p</italic> &#x0003c; 0.05) was assessed between the experimental groups and controls (no pectin), which were assumed to be 100%. Representative images of bacteria adhering to untreated HCT 116 cells (<bold>B1</bold>,<bold>C1</bold>) and cells treated with PX (<bold>B</bold>) or PCX (<bold>C</bold>) at concentrations of 0.125 mg/mL (<bold>B2</bold>,<bold>C2</bold>), 0.25 mg/mL (<bold>B3</bold>,<bold>C3</bold>), and 0.5 mg/mL (<bold>B4</bold>,<bold>C4</bold>). Wright&#x02013;Giemsa stain, 100&#x000d7; magnification.</p></caption><graphic xlink:href="pharmaceuticals-18-00152-g001" position="float"/></fig></floats-group></article>